Keating Anne, Pineda Roberto, Colby Kathryn
Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, USA.
Semin Ophthalmol. 2010 Sep-Nov;25(5-6):249-55. doi: 10.3109/08820538.2010.518503.
Riboflavin-induced ultraviolet light (UV) cross linking has received a significant amount of attention in recent years. It is currently approved in Europe as a treatment for keratoconus and is also being used for other corneal disorders. The goal of this paper is to review in detail seminal papers and studies that have been done to support cross linking as a safe and effective treatment for patients with early stages of keratoconus.
近年来,核黄素诱导的紫外线交联受到了广泛关注。目前,它在欧洲已被批准用于治疗圆锥角膜,也被用于其他角膜疾病。本文的目的是详细回顾那些支持交联作为圆锥角膜早期患者安全有效治疗方法的重要论文和研究。